Biohaven Ltd. (BHVN)
Official siteHEALTHCARE • BIOTECHNOLOGY • NYSE
Market Cap: $2.08B
Last updated: Nov 17, 2026 at 4:15 PM ET
Biohaven Ltd. (BHVN) Statistics
Biohaven (BHVN) has a market cap of $2.08B and an enterprise value of $2.25B. Its share count is up 42.74% from a year earlier. Revenue fell 100.00% over the last 12 months from the 12 months before.
Total Valuation
Enterprise value is 8.08% above the market cap, as debt exceeds cash.
| Market Cap | $2.08B |
|---|---|
| Enterprise Value | $2.25B |
| Latest price (Nov 17, 2026) | $13.24 |
Key Dates
The next earnings report is expected on Mar 1, 2027, covering the quarter ending Dec 31, 2026.
| Next Earnings Date | Mar 1, 2027 (expected) |
|---|---|
| Last Earnings Date | Oct 29, 2026 |
| Fiscal Year End | December |
Price Statistics
The stock is up 59.52% over 52 weeks and trades 1.56% below its 50-day average.
| Beta (1Y) | 1.37 |
|---|---|
| 52-Week Change | +59.52% |
| 1-Month Change | +16.65% |
| 3-Month Change | -6.36% |
| 6-Month Change | +57.81% |
| Total Return (1Y) | +59.52% |
| Total Return (3Y CAGR) | -23.94% |
| Return vs SPY (1Y) | +28.55% |
| Max Drawdown (1Y) | -41.21% |
| Max Drawdown (3Y) | -86.96% |
| Sharpe Ratio (1Y) | 0.42 |
| Correlation with SPY (1Y) | 0.24 |
| 50-Day Average | $13.45 |
| 200-Day Average | $12.34 |
| 52-Week Range | $8.03 to $18.24 |
| RSI (14 Days) | 44.2 |
| Average Volume (20 Days) | 3.82M |
Financial Position
Current assets cover 3.05x current liabilities.
| Current Ratio | 3.05x |
|---|---|
| Quick Ratio | 3.05x |
Returns and Efficiency
Return on invested capital is -315.86% over the last 12 months.
| Return on Assets (ROA) | -205.81% |
|---|---|
| Return on Invested Capital (ROIC) | -315.86% |
| Return on Capital Employed (ROCE) | -261.05% |
Scores
BHVN has a Piotroski F-Score of 1 of 9, in the weak band of 0 to 2.
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Piotroski F-Score | 1 of 9 |
|---|---|
| Piotroski Strength | Weak |
Income Statement
Revenue was $0 over the last 12 months.
| Revenue | $0 |
|---|---|
| Revenue Growth (YoY) | -100.00% |
| Gross Profit | -$960.00K |
| Operating Income | -$524.48M |
| Pretax Income | -$541.73M |
| Net Income | -$542.68M |
| EBITDA | -$515.06M |
| EBIT | -$524.48M |
| Reported EPS (TTM) | -$3.36 |
Trailing 12 months through Sep 30, 2026.
Balance Sheet
| Cash and Equivalents | $95.75M |
|---|---|
| Total Debt | $264.29M |
| Net Debt | $168.54M |
| Net Debt Per Share | $1.12 |
| Working Capital | $128.75M |
| Shareholder Equity | -$98.25M |
| Tangible Book Value | -$118.04M |
| Total Assets | $263.68M |
| Total Liabilities | $361.92M |
Balance sheet as of Sep 30, 2026.
Cash Flow
After $642.00K of capital spending, operating cash flow left -$473.17M of free cash flow.
| Operating Cash Flow | -$472.53M |
|---|---|
| Capital Expenditures | $642.00K |
| Free Cash Flow | -$473.17M |
| FCF Per Share | -$3.13 |
| Depreciation and Amortization | $9.42M |
Trailing 12 months through Sep 30, 2026.
Growth
| Book Value Per Share Growth (2Y CAGR) | -71.55% |
|---|---|
| Tangible Book Per Share Growth (2Y CAGR) | -77.07% |
Dividends and Yields
BHVN does not pay a dividend. Its free cash flow yield is -23.66%.
| FCF Yield | -23.66% |
|---|---|
| Buyback Yield | -18.68% |
| Shareholder Yield | -18.68% |
Peer Position
Against 5 similar companies, BHVN has the lowest ROIC.
ROICPeer median -28.26%
Revenue Growth (Trailing 4 Quarters, YoY)Peer median +29.89%
| ROIC | -315.86% vs -28.26% median |
|---|---|
| Revenue Growth (Trailing 4 Quarters, YoY) | -100.00% vs +29.89% median |
Price Target
Analyst price targets are part of paid GNG plans. See plans
Frequently Asked Questions About BHVN
What is BHVN's market cap?
Biohaven has a market cap of $2.08B. Its enterprise value, which adds debt and subtracts cash, is $2.25B.
How many shares of BHVN are outstanding?
Biohaven has 151.04M shares outstanding. The count is up 42.74% from a year earlier.
Does BHVN pay a dividend?
No. Biohaven does not pay a dividend.
How much debt does BHVN have?
Biohaven has $264.29M of total debt and $95.75M of cash and equivalents, a net debt position of $168.54M.
BHVN pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Competitors